# Petco Health and Wellness Company, Inc. (WOOF)

> Source: Nexqual · https://nexqual.com/WOOF · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Petco Health and Wellness Company, Inc. (WOOF), nexqual.com/WOOF" · informational, not investment advice.

**Price:** USD 2.53 (+9.52% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 2.31 · day 2.3–2.55 · 52w 2.14–3.87 · market cap $725M · NMS

## Key facts
- Last four reported quarters (through Aug 1, 2026): revenue $5.97B, net income $30.3M (0.5% margin), free cash flow $238M (SEC filings).
- Valuation: P/E 23.9x (avg 84.9x at the last 1 fiscal year-ends), EV/EBITDA 3.1x, net debt $297M.
- Insider open-market sales, last ~7 months: 2 Form 4 filings, $1.1M; 2 not under a Rule 10b5-1 plan ($1.1M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Hold (mean 3.08 on a 1–5 scale) (12 analysts), mean target USD 3.47 (range 2.11–5).
- Total return with dividends: 1Y -31.6% vs S&P 500 +14.9%; 5Y -89.3% vs S&P 500 +80.3%.
- Next earnings: 2026-09-02, EPS estimate USD 0.04, revenue estimate $1.48B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.81B | $6.04B | $6.26B | $6.12B | $5.96B | $5.97B |
| Gross profit | $2.43B | $2.43B | $2.35B | $2.32B | $2.31B | — |
| Operating income | $266M | $226M | -$1.18B | $7.1M | $120M | $133M |
| Net income | $164M | $90.8M | -$1.28B | -$102M | $9.1M | $30.3M |
| EPS (diluted) | $0.62 | $0.34 | -$4.78 | -$0.37 | $0.03 | — |
| Free cash flow | $119M | $68.0M | -$9.9M | $49.7M | $187M | $238M |
| Gross margin | 41.8% | 40.2% | 37.6% | 38.0% | 38.7% | — |
| Operating margin | 4.6% | 3.7% | -18.9% | 0.1% | 2.0% | 2.2% |
| Net margin | 2.8% | 1.5% | -20.5% | -1.7% | 0.2% | 0.5% |
| Revenue growth | +18.0% | +3.9% | +3.6% | -2.2% | -2.5% | — |
| Cash + short-term investments | $212M | $202M | $125M | $166M | $257M | — |
| Total debt | $1.64B | $1.63B | $1.58B | $1.58B | $1.49B | — |
Fiscal years end Jan. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Aug 1, 2026)
P/E 23.9x · P/S 0.1x · EV/EBITDA 3.1x · EV/Sales 0.2x · P/FCF 3.0x · P/B 0.6x · FCF yield 32.82% · Earnings yield 4.18% · Net debt $297M · EV $1.02B
P/E at fiscal year-ends: Jan 2026 84.9x.

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 2 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-07-09 | May Holly | Chief Human Resources Officer | 200,000 | $508K | 13.1% | No | Too little history (no open-market trades in 2023–2025) |
| 2026-07-07…2026-07-08 | May Holly | Chief Human Resources Officer | 250,000 | $638K | 14.1% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Hold (mean 3.08 on a 1–5 scale), 12 analysts; mean target USD 3.47 (low 2.11, high 5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-09-29 | Evercore ISI Group | Target lowered | In-Line | $4 → $3 |
| 2026-09-03 | BNP Paribas | Target lowered | Underperform | $2.34 → $2.11 |
| 2026-09-03 | UBS | Target lowered | Neutral | $4 → $3.5 |
| 2026-09-03 | Baird | Target raised | Neutral | $3 → $3.25 |
| 2026-09-01 | Evercore ISI Group | Target raised | In-Line | $3.5 → $4 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | -31.6% | -89.3% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -31.7% | -36.0% |
| Volatility (annualized) | 57.8% | 69.4% |
| Max drawdown | -42.9% (Oct 2025→Oct 2026) | -94.1% (Nov 2021→Apr 2024) |

## Peers (Specialty Retail)
BWMX (Betterware de Mexico, S.A.P.I. ) USD 15.98 +0.57% · WINA (Winmark Corporation) USD 285.97 +1.85% · BNED (Barnes & Noble Education, Inc) USD 13.95 +1.45% · HZO (MarineMax, Inc.  (FL)) USD 52.38 -0.08% · EYE (National Vision Holdings, Inc.) USD 18.87 +6.49% · SVV (Savers Value Village, Inc.) USD 9.85 -0.30%

## More
Full page: https://nexqual.com/WOOF · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Revenue by product line (quarter ended 2026-08-01)

| Line | Revenue | Share | YoY |
|---|---|---|---|
| Product | $1.22B | 81.7% | -0.7% |
| — Consumables (part of Product) | $731.3M | 49.1% | +0.2% |
| — Supplies & Companion Animals (part of Product) | $485.6M | 32.6% | -2.0% |
| Services & Other | $272.4M | 18.3% | +3.6% |
| Total revenue | $1.49B | 100% | — |

## Company outlook (8-K filed 2026-09-02)

- "Announces $75 Million Debt Prepayment, Progressing Toward 2x Leverage 1 Target Reaffirms Fiscal 2026 Outlook San Diego, September 2, 2026 – Petco (Nasdaq: WOOF), the retailer "where the pets go" to find everything they need to live their best lives, today reported its second quarter 2026 financial results."
- "Prior to the relaunch, sales were trending ahead of our Q2 outlook. • Gross profit increased to $591.1 million; gross margin rate increased 37 basis points to 39.7% of net sales, compared to $585.3 million or 39.3% of net sales last year."

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-10-31) | $0.04 | $0.06 | -21.6% | $1.48B | 7 |
| Next quarter (ends 2027-01-31) | $0.06 | $0.08 | -23.6% | $1.53B | 7 |
| Current fiscal year (ends 2027-01-31) | $0.26 | $0.22 | +16.0% | $5.99B | 8 |
| Next fiscal year (ends 2028-01-31) | $0.27 | $0.28 | -3.7% | $6.06B | 8 |

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-12-18 | 56 | 72.6% | ±23.1% |
| 2027-01-15 | 84 | 59.7% | ±27.1% |
| 2027-03-19 | 147 | 59.7% | ±32.1% |
| 2027-06-17 | 237 | 92.2% | ±64.3% |